Diane C Roth, OT in Aitkin, MN - Occupational Therapist

Diane C Roth, OT is a Occupational Therapist based in Aitkin, Minnesota. Diane C Roth is licensed to practice in Minnesota (license number 101257) and her current practice location is 200 Bunker Hill Dr, Aitkin, Minnesota. She can be reached at her office (for appointments etc.) via phone at (218) 927-2121.

NPI number for Diane C Roth is 1578830329 and her current mailing address is 200 Bunker Hill Dr, Aitkin, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1578830329.

Contact Information

	Diane C Roth, OT
	200 Bunker Hill Dr, Aitkin, MN 56431-1865
	(218) 927-2121
	Not Available

Healthcare Provider's Profile

Full Name	Diane C Roth
Gender	Female
Speciality	Occupational Therapist
Location	200 Bunker Hill Dr, Aitkin, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1578830329
Provider Enumeration Date: 11/22/2011
Last Update Date: 11/22/2011

Medical Identifiers

Medical identifiers for Diane C Roth such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578830329	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	101257 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Diane C Roth is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Diane C Roth, OT 200 Bunker Hill Dr, Aitkin, MN 56431-1865 Ph: (218) 927-2121	Diane C Roth, OT 200 Bunker Hill Dr, Aitkin, MN 56431-1865 Ph: (218) 927-2121

News Archive

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.

MRI is both safe and accurate for diagnosing pregnant women with acute pain in the abdomen and pelvis

MRI is both safe and accurate for diagnosing pregnant women with acute pain in the abdomen and pelvis, surpassing the limits of both CT and ultrasound for this purpose, according to a new study by researchers from University of North Carolina Hospitals in Chapel Hill, NC.

Bilingual children reliably acquire English skills by age 5, shows study

In the United States, more than 12 million children hear a minority language at home from birth. More than two-thirds hear English as well, and they reach school age with varying levels of proficiency in two languages.

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases.

Mayo Clinic study identifies benchmarks for postsurgical outcomes in patients with colorectal cancer

About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating primary tumors within the colon and metastatic tumors in the liver continues to evolve; however, it typically involves chemotherapy plus surgical removal (resection) of both types of tumors. However, experts continue to debate whether surgical resection of primary tumors and metastatic tumors should be performed at the same time (synchronously) or in separate operations (sequentially).

Occupational Therapist in Aitkin, MN

Ms. Wendy Joan Mack, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 213 1st Ave Se, Aitkin, MN 56431 Phone: 218-839-1792
Karen R Goetzfridt-gidney, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 Minnesota Ave S, Aitkin, MN 56431 Phone: 218-927-5526

Diane C Roth, OT - Occupational Therapist in Aitkin, MN